Skip to main content
Premium Trial:

Request an Annual Quote

Evosep Receives $40M Investment From Novo Holdings

NEW YORK – Danish investment firm Novo Holdings said Monday that it has invested $40 million in proteomics-focused liquid chromatography firm Evosep.

Odense, Denmark-based Evosep said it will use the funds to advance clinical proteomics applications using its LC technology and to expand its global presence including in the US market.

Founded in 2016, Evosep has targeted high-throughput proteomics applications in particular, optimizing its system for robustness and reproducibility across thousands of samples.

"Evosep's technology can profoundly impact the diagnosis and treatment of diseases," Stephen Van Helden, principal at Novo Holdings, said in a statement. "Its platform addresses some of the most common technical pain points that have historically held back the widespread application of proteomics."

Concurrent with the investment, Van Helden is joining Evosep's board of directors.

Evosep CEO Christian Ravnsborg said in a statement that Novo Holdings' "combined experience and investment will enable us to accelerate our already strong growth and further expand our platform towards bedside-care proteomics, both independently and through our many vendor relationships."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.